Serina Therapeutics, Inc.SERNYSE
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
213.23%
↑ 1197% above average
Average (8y)
16.43%
Historical baseline
Range
High:213.23%
Low:-58.59%
Volatility
1654.0%
High variability
| Period | Value |
|---|---|
| 2024 | 213.23% |
| 2023 | 51.80% |
| 2022 | -58.59% |
| 2021 | 6.05% |
| 2020 | -33.00% |
| 2019 | -0.13% |
| 2018 | 1.63% |
| 2017 | -33.09% |
| 2016 | 0.00% |